NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球心臟再同步化治療市場規模調查:各產品類型,各終端用戶,各地區預測(2021∼2027年)

Global Cardiac Resynchronization Therapy Market Size study, by Product type, by End User and Regional Forecasts 2021-2027

出版商 Bizwit Research & Consulting LLP 商品編碼 1008737
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球心臟再同步化治療市場規模調查:各產品類型,各終端用戶,各地區預測(2021∼2027年) Global Cardiac Resynchronization Therapy Market Size study, by Product type, by End User and Regional Forecasts 2021-2027
出版日期: 2021年05月25日內容資訊: 英文
簡介

全球心臟再同步化治療的市場規模在2020年估算為約43億美金。

該市場在2021年∼2027年間的預測期間內,預計將以超越4.4%的健全的成長率擴大。

CRT 市場增長的主要貢獻者是心髒病和心力衰竭的發病率上升以及向久坐的生活方式的轉變。由於預期壽命的增加,老年人口的增加也支持了市場的增長。此外,技術進步和新興市場有可能在市場上開闢新機遇。然而,在預測期內,缺乏熟練的專業人員和高昂的設備更換成本預計將阻礙市場增長。

本報告提供全球心臟再同步化治療市場相關調查,市場概要,以及各產品類型,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 全球心臟再同步化治療市場定義和範圍

第3章 全球心臟再同步化治療市場動態

  • 心臟再同步化治療市場影響分析(2019∼2027年)

第4章 全球心臟再同步化治療市場產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論

第5章 全球心臟再同步化治療市場,各產品類型

市場概述

  • 全球心臟再同步化治療市場,各產品類型:效能-潛在的分析
  • 全球心臟再同步化治療市場預算與預測產品,各產品類型:2018∼2027年(10億美元)
  • 心臟再同步化治療市場,子區隔分析
    • 心臟再同步化治療心臟去顫器
    • 心臟同步治療起搏器

第6章 全球心臟再同步化治療市場,各終端用戶

市場概述

  • 全球心臟再同步化治療市場,各終端用戶:效能-潛在的分析
  • 全球心臟再同步化治療市場預算與預測產品,各終端用戶:2018∼2027年(10億美元)
  • 心臟再同步化治療市場,子區隔分析
    • 醫院和心臟中心
    • 門診病人手術中心

第7章 全球心臟再同步化治療市場,地區分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他
  • 南美概述
    • 巴西
    • 墨西哥
  • 其他地區

第8章 競爭資訊

  • 頂級市場策略
  • 企業簡介
    • Medtronic, PLC.
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Biotronik
    • Medico S.P.A.
    • Microport Scientific Corporation
    • St. Jude Medical
    • LivaNova Plc
    • Lepu Medical Technology Co. Ltd.
    • Shree Pacetronix Ltd.

第9章 調查流程

目錄

Global Cardiac Resynchronization Therapy Market is valued approximately at USD 4.3 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.4% over the forecast period 2021-2027. The major factors contributing to the growth of the CRT market are rising incidences of cardiac disorders and heart failure and shift towards a sedentary lifestyle among the population. The rise in geriatric population due to increased life expectancy is also fueling the market growth. According to the data of United Nations, the number of persons aged above 65 years was estimated to be 727 million in 2020 and the number is projected to be more than double by 2050. Also, the percentage of older people among the global population is anticipated to increase from 9.3 percent in 2020 to 16 percent in 2050. Furthermore, technological advancements and new emerging markets are likely to open up new opportunities for the market. However, lack of skilled professionals and high device replacement cost may hinder the growth of the market over the forecast period.

The regional analysis of global Cardiac Resynchronization Therapy Market is based on key regions including Asia Pacific, Europe, North America, Latin America, and the rest of the world. North America is dominating the market in terms of share and is also expected to exhibit the highest CAGR over the forecast period. This growth can be attributed to the growing healthcare expenditure, and the advent of new technological advancements in the region.

Major market player included in this report are:

Medtronic, PLC.

Abbott Laboratories

Boston Scientific Corporation

Biotronik

Medico S.P.A.

MicroPort Scientific Corporation

St. Jude Medical

LivaNova Plc

Lepu Medical Technology Co. Ltd.

Shree Pacetronix Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Cardiac Resynchronized Therapy Defibrillators

Cardiac Resynchronized Therapy Pacemakers

By End User:

Hospitals & Cardiac Centers

Ambulatory Surgery Centers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027.

Target Audience of the Global Cardiac Resynchronization Therapy Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Cardiac Resynchronization Therapy Market, by Region, 2019-2027 (USD Billion)
    • 1.2.2. Cardiac Resynchronization Therapy Market, by Product Type, 2019-2027 (USD Billion)
    • 1.2.3. Cardiac Resynchronization Therapy Market, by End User, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cardiac Resynchronization Therapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cardiac Resynchronization Therapy Market Dynamics

  • 3.1. Cardiac Resynchronization Therapy Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing geriatric population
      • 3.1.1.2. Rising incidence of target diseases
    • 3.1.2. Market Restraint
      • 3.1.2.1. Battery life and device replacement cost
      • 3.1.2.2. Shortage of skilled cardiac surgeons
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancements
      • 3.1.3.2. Emerging markets

Chapter 4. Global Cardiac Resynchronization Therapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Cardiac Resynchronization Therapy Market, by Product Type

a. Market Snapshot

  • 5.1. Global Cardiac Resynchronization Therapy Market by Product Type, Performance - Potential Analysis
  • 5.2. Global Cardiac Resynchronization Therapy Market Estimates & Forecasts by Product Type 2018-2027 (USD Billion)
  • 5.3. Cardiac Resynchronization Therapy Market, Sub Segment Analysis
    • 5.3.1. Cardiac Resynchronization Therapy Defibrillators
    • 5.3.2. Cardiac Resynchronization Therapy Pacemakers

Chapter 6. Global Cardiac Resynchronization Therapy Market, by End User

b. Market Snapshot

  • 6.1. Global Cardiac Resynchronization Therapy Market by End User, Performance - Potential Analysis
  • 6.2. Global Cardiac Resynchronization Therapy Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
  • 6.3. Cardiac Resynchronization Therapy Market, Sub Segment Analysis
    • 6.3.1. Hospitals & Cardiac Centers
    • 6.3.2. Ambulatory Surgery Centers

Chapter 7. Global Cardiac Resynchronization Therapy Market, Regional Analysis

  • 7.1. Cardiac Resynchronization Therapy Market, Regional Market Snapshot
  • 7.2. North America Cardiac Resynchronization Therapy Market
    • 7.2.1. U.S. Cardiac Resynchronization Therapy Market
      • 7.2.1.1. Product Type breakdown estimates & forecasts, 2018-2027
      • 7.2.1.2. End User breakdown estimates & forecasts, 2018-2027
    • 7.2.2. Canada Cardiac Resynchronization Therapy Market
  • 7.3. Europe Cardiac Resynchronization Therapy Market Snapshot
    • 7.3.1. U.K. Cardiac Resynchronization Therapy Market
    • 7.3.2. Germany Cardiac Resynchronization Therapy Market
    • 7.3.3. France Cardiac Resynchronization Therapy Market
    • 7.3.4. Spain Cardiac Resynchronization Therapy Market
    • 7.3.5. Italy Cardiac Resynchronization Therapy Market
    • 7.3.6. Rest of Europe Cardiac Resynchronization Therapy Market
  • 7.4. Asia-Pacific Cardiac Resynchronization Therapy Market Snapshot
    • 7.4.1. China Cardiac Resynchronization Therapy Market
    • 7.4.2. India Cardiac Resynchronization Therapy Market
    • 7.4.3. Japan Cardiac Resynchronization Therapy Market
    • 7.4.4. Australia Cardiac Resynchronization Therapy Market
    • 7.4.5. South Korea Cardiac Resynchronization Therapy Market
    • 7.4.6. Rest of Asia Pacific Cardiac Resynchronization Therapy Market
  • 7.5. Latin America Cardiac Resynchronization Therapy Market Snapshot
    • 7.5.1. Brazil Cardiac Resynchronization Therapy Market
    • 7.5.2. Mexico Cardiac Resynchronization Therapy Market
  • 7.6. Rest of The World Cardiac Resynchronization Therapy Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Medtronic, PLC.
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Abbott Laboratories
    • 8.2.3. Boston Scientific Corporation
    • 8.2.4. Biotronik
    • 8.2.5. Medico S.P.A.
    • 8.2.6. Microport Scientific Corporation
    • 8.2.7. St. Jude Medical
    • 8.2.8. LivaNova Plc
    • 8.2.9. Lepu Medical Technology Co. Ltd.
    • 8.2.10. Shree Pacetronix Ltd.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 2. Global Cardiac Resynchronization Therapy Market, report scope
  • TABLE 3. Global Cardiac Resynchronization Therapy Market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 4. Global Cardiac Resynchronization Therapy Market estimates & forecasts by Product Type 2018-2027 (USD Billion)
  • TABLE 5. Global Cardiac Resynchronization Therapy Market estimates & forecasts by End User 2018-2027 (USD Billion)
  • TABLE 6. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 7. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Global Cardiac Resynchronization Therapy Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. Global Cardiac Resynchronization Therapy Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. U.S. Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 23. U.S. Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 24. U.S. Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. Canada Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 26. Canada Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. Canada Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. UK Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 29. UK Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. UK Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. Germany Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 32. Germany Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. Germany Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. France Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 35. France Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. France Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. Spain Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 38. Spain Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. Spain Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. Italy Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 41. Italy Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. Italy Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. ROE Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 44. ROE Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. ROE Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. China Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 47. China Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. China Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. India Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 50. India Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. India Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. Japan Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 53. Japan Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. Japan Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. Australia Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 56. Australia Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 57. Australia Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 58. South Korea Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 59. South Korea Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 60. South Korea Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 61. ROPAC Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 62. ROPAC Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 63. ROPAC Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 64. Brazil Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 65. Brazil Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 66. Brazil Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 67. Mexico Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 68. Mexico Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 69. Mexico Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 70. ROLA Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 71. ROLA Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 72. ROLA Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 73. ROW Cardiac Resynchronization Therapy Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 74. ROW Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 75. ROW Cardiac Resynchronization Therapy Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 76. List of secondary sources used in the study of global Cardiac Resynchronization Therapy Market.
  • TABLE 77. List of primary sources used in the study of global Cardiac Resynchronization Therapy Market.
  • TABLE 78. Years considered for the study.
  • TABLE 79. Exchange rates considered.

LIST OF FIGURES

List of figures

  • FIG 1. Global Cardiac Resynchronization Therapy Market, research methodology
  • FIG 2. Global Cardiac Resynchronization Therapy Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Cardiac Resynchronization Therapy Market, key trends 2020
  • FIG 5. Global Cardiac Resynchronization Therapy Market, growth prospects 2021-2027
  • FIG 6. Global Cardiac Resynchronization Therapy Market, porters 5 force model
  • FIG 7. Global Cardiac Resynchronization Therapy Market, pest analysis
  • FIG 8. Global Cardiac Resynchronization Therapy Market, value chain analysis
  • FIG 9. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
  • FIG 15. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
  • FIG 16. Global Cardiac Resynchronization Therapy Market by segment, 2018 & 2027 (USD Billion)
  • FIG 17. Global Cardiac Resynchronization Therapy Market, regional snapshot 2018 & 2027
  • FIG 18. North America Cardiac Resynchronization Therapy Market 2018 & 2027 (USD Billion)
  • FIG 19. Europe Cardiac Resynchronization Therapy Market 2018 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Cardiac Resynchronization Therapy Market 2018 & 2027 (USD Billion)
  • FIG 21. Latin America Cardiac Resynchronization Therapy Market 2018 & 2027 (USD Billion)
  • FIG 22. Global Cardiac Resynchronization Therapy Market, company market share analysis (2020)